5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Results of T cell depleted (TCD) myeloablative hematopoietic stem cell transplants (HSCT) in patients with hematologic malignancies >= 55 yrs of age
    Meeting Abstract

    Jakubowski, A. A.; Papadopoulos, E. B.; Castro-Malaspina, H. R.; Hsu, K.; Perales, M. A.; Van Den Brink, M.; Young, J. W.; O'Reilly, R. J.
    Blood (2005)

    Fulltext@MSK | Save
  • Correlation of EGFR and KRAS mutation status, response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors and survival with histologic subtypes of adenocarcinoma of the lung
    Meeting Abstract

    Hussain, S.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.; Pao, W.; Riely, G.; Rizvi, N.; Gomez, J. E.; Miller, V.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Analysis of EGFR amplification in pulmonary adenocarcinomas by chromogenic in situ hybridization
    Meeting Abstract

    Hussain, S.; Pao, W.; Pan, Q.; Chen, B.; Ladanyi, M.; Zakowski, M. F.
    Modern Pathology (2005)

    Fulltext@MSK | Save
  • Analysis of EGFR amplification in pulmonary adenocarcinomas by chromogenic in situ hybridization
    Meeting Abstract

    Hussain, S.; Pao, W.; Pan, Q.; Chen, B.; Ladanyi, M.; Zakowski, M. F.
    Laboratory Investigation (2005)

    Fulltext@MSK | Save
  • EGFR mutation analysis in atypical adenomatous hyperplasia of the lung
    Meeting Abstract

    Hussain, S.; Pan, Q.; Ladanyi, M.; Zakowski, M. F.
    Laboratory Investigation (2005)

    Fulltext@MSK | Save
  • EGFR mutation analysis in atypical adenomatous hyperplasia of the lung
    Meeting Abstract

    Hussain, S.; Pan, Q.; Ladanyi, M.; Zakowski, M. F.
    Modern Pathology (2005)

    Fulltext@MSK | Save
  • Missing killer immunoglobulin-like receptor (KIR) ligand confers protection from relapse in recipients of unrelated hematopoietic cell transplantation (HCT) for AML
    Meeting Abstract

    Hsu, K. C.; Malkki, M.; Gooley, T. A.; Dupont, B.; Petersdorf, E. W.
    Biology of Blood and Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • Lack of HLA-C group 2 KIR ligand in the recipient predictive of lower relapse and higher overall survival in unrelated transplants
    Meeting Abstract

    Hsu, K. C.; Malkki, M.; Gooley, T.; Pinto-Agnello, C.; Dupont, B.; Petersdorf, E.
    Tissue Antigens (2005)

    Fulltext@MSK | Save
  • A phase I dose escalation trial of pulsatile high dose gefitinib and docetaxel in patients with an advanced solid tumor
    Meeting Abstract

    Fury, M. G.; Kris, M.; Solit, D.; Pfister, D. G.; Azzoli, C. G.; Henry, R.; Su, Y. B.; Rizvi, N.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Evaluation of plasma insulin-like growth factor binding protein 2 (IGFBP-2) as a biomarker for 17-allylamino-17-demethoxygeldanamycin (17-AAG) treatment of adult patients (pts) with advanced solid tumors
    Meeting Abstract

    Eiseman, J. L.; Guo, J.; Weinbaum, B.; Ramanathan, R. K.; Belani, C. P.; Solit, D. B.; Scher, H. I.; Ivy, S. P.; Zuhowski, E. G.; Egorin, M. J.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save